tirzepatide compound hers COMPOUNDED TIRZEPATIDE sustainable wellness goals. Tirzepatide

Expanding Indications: Beyond Obesity and Diabetes The GLP-1 drug pipeline in 2026 reaches well beyond weight management and glycaemic control

Research shows about 70% of adults lose at least 5% of their body weight on Qsymia

This is broadly consistent with guidance from the British Dietetic Association (BDA) and European Society for Clinical Nutrition and Metabolism (ESPEN)

Some patients manage hyperthyroidism with medications like propranolol, which can interact with weight loss medications in different ways

Both medications are common but work differently

The most valuable benefit is the potential for lasting change